Log In
Print
BCIQ
Print
Print this Print this
 

Octaplas

  Manage Alerts
Collapse Summary General Information
Company Octapharma AG
DescriptionA solution for infusion containing human plasma proteins
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard Indication Hematology (unspecified)
Indication DetailsTo manage preoperative or bleeding patients who require replacement of multiple plasma coagulation factors and for the substitution of intentionally removed plasma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today